SARS-CoV-2 envelope protein-derived extracellular vesicles act as potential media for viral spillover.

SARS-CoV-2 envelope protein-derived extracellular vesicles act as potential media for viral spillover.

Publication date: Jul 01, 2024

Extracellular vesicles (EVs) are shown to be a novel viral transmission model capable of increasing a virus’s tropism. According to our earlier research, cells infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or transfected with envelope protein plasmids generate a novel type of EVs that are micrometer-sized and able to encase virus particles. Here, we showed the capacity of these EVs to invade various animals both in vitro and in vivo independent of the angiotensin-converting enzyme 2 receptor. First, via macropinocytosis, intact EVs produced from Vero E6 (monkey) cells were able to enter cells from a variety of animals, including cats, dogs, bats, hamsters, and minks, and vice versa. Second, when given to zebrafish with cutaneous wounds, the EVs showed favorable stability in aqueous environments and entered the fish. Moreover, infection of wild-type (WT) mice with heterogeneous EVs carrying SARS-CoV-2 particles led to a strong cytokine response and a notable amount of lung damage. Conversely, free viral particles did not infect WT mice. These results highlight the variety of processes behind viral transmission and cross-species evolution by indicating that EVs may be possible vehicles for SARS-CoV-2 spillover and raising risk concerns over EVs’ potential for viral gene transfer.

Concepts Keywords
Bats Angiotensin-Converting Enzyme 2
Coronavirus Angiotensin-Converting Enzyme 2
Cutaneous Animals
Vivo Cats
Zebrafish cellular signal transduction
Chiroptera
Chlorocebus aethiops
coronavirus
Coronavirus Envelope Proteins
Coronavirus Envelope Proteins
COVID-19
Cricetinae
cytokine/chemokine
Dogs
envelope protein, SARS-CoV-2
Extracellular Vesicles
Humans
immune responses
Mice
SARS-CoV-2
Vero Cells
virus classification
Zebrafish

Semantics

Type Source Name
disease VO Envelope protein
disease VO Severe acute respiratory syndrome coronavirus 2
drug DRUGBANK Angiotensin II
disease MESH infection
disease VO viral gene
disease MESH COVID-19

Original Article

(Visited 1 times, 1 visits today)